Iovance Biotherapeutics, Inc.
IOVA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001425205
No open-market purchases or sales by Iovance Biotherapeutics, Inc. insiders were filed in the last 90 days; 293 institutions reported holding it in 13F filings for Q2 2026, worth $1.19B in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Iovance Biotherapeutics, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 228
- +11 vs. Q2 2023
- Shares held
- 213.1M
- +14.3M (+7.2%) vs. Q2 2023
- Total value
- $970.0M
- −$429.4M (−30.7%) vs. Q2 2023
- New holders
- 41
- 107 more added
- Sold out
- 30
- 52 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IOVA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 293 | $1.19B |
| Q1 2026 | 286 | $943.8M |
| Q4 2025 | 263 | $713.7M |
| Q3 2025 | 253 | $462.3M |
| Q2 2025 | 255 | $379.3M |
| Q1 2025 | 303 | $798.9M |
| Q4 2024 | 302 | $1.79B |
| Q3 2024 | 286 | $2.21B |
| Q2 2024 | 295 | $1.86B |
| Q1 2024 | 273 | $3.22B |
| Q4 2023 | 236 | $1.69B |
| Q3 2023 | 228 | $970.0M |
| Q2 2023 | 219 | $1.44B |
| Q1 2023 | 230 | $1.25B |
| Q4 2022 | 218 | $1.11B |
| Q3 2022 | 242 | $1.48B |
| Q2 2022 | 238 | $1.75B |
| Q1 2022 | 248 | $2.60B |
| Q4 2021 | 246 | $2.96B |
| Q3 2021 | 244 | $3.88B |
| Q2 2021 | 234 | $4.22B |
| Q1 2021 | 252 | $4.98B |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Iovance Biotherapeutics, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Charles Schwab Investment Management Inc | 1,692,533 | $7.70M | 0.00% | +201,311+13.5% | Added |
| Rice Hall James & Associates, LLC | 1,722,711 | $7.84M | 0.50% | −36,048−2.0% | Reduced |
| Hood River Capital Management LLC | 1,992,335 | $9.07M | 0.29% | +16,784+0.8% | Added |
| Northern Trust Corp | 1,993,179 | $9.07M | 0.00% | +180,930+10.0% | Added |
| 683 Capital Management, LLC | 2,050,000 | $9.33M | 0.95% | +650,000+46.4% | Added |
| Long Focus Capital Management, LLC | 2,470,521 | $11.2M | 1.61% | +593,707+31.6% | Added |
| Morgan Stanley | 2,482,125 | $11.3M | 0.00% | −1,015,483−29.0% | Reduced |
| Principal Financial Group Inc | 2,643,155 | $12.0M | 0.01% | +772,905+41.3% | Added |
| JPMorgan Chase & Co | 2,746,356 | $12.5M | 0.00% | +111,069+4.2% | Added |
| Candriam Luxembourg S.C.A. | 2,747,853 | $12.5M | 0.10% | +1,020,037+59.0% | Added |
| Credit Suisse AG | 2,843,469 | $12.9M | 0.01% | +49,345+1.8% | Added |
| MPM Oncology Impact Management LP | 3,287,397 | $15.0M | 3.99% | +337,279+11.4% | Added |
| Price T Rowe Associates Inc | 3,597,120 | $16.4M | 0.00% | −66,253−1.8% | Reduced |
| Boxer Capital, LLC | 3,705,133 | $16.9M | 0.90% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 3,763,638 | $17.1M | 0.00% | +228,371+6.5% | Added |
| Dimensional Fund Advisors LP | 3,978,385 | $18.1M | 0.01% | +1,881,382+89.7% | Added |
| Balyasny Asset Management LLC | 4,476,836 | $20.4M | 0.06% | +2,937,029+190.7% | Added |
| OrbiMed Advisors LLC | 4,707,458 | $21.4M | 0.50% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 4,749,411 | $21.6M | 0.00% | +611,049+14.8% | Added |
| Artisan Partners Limited Partnership | 5,036,479 | $22.9M | 0.04% | +609,738+13.8% | Added |
| Avoro Capital Advisors LLC | 6,700,000 | $30.5M | 0.48% | 00.0% | Unchanged |
| Pictet Asset Management Holding SA | 6,913,684 | $31.5M | 0.04% | +6,913,684 | New |
| Millennium Management LLC | 7,820,074 | $35.6M | 0.04% | +4,239,406+118.4% | Added |
| Perceptive Advisors LLC | 11,962,938 | $54.4M | 1.83% | −2,073,472−14.8% | Reduced |
| State Street Corp | 16,732,269 | $76.1M | 0.00% | +3,166,471+23.3% | Added |
| BlackRock Inc. | 18,376,429 | $83.6M | 0.00% | +1,374,638+8.1% | Added |
| MHR Fund Management LLC | 19,997,103 | $91.0M | 11.15% | +8,000,000+66.7% | Added |
| Vanguard Group Inc | 22,143,470 | $100.8M | 0.00% | +1,748,082+8.6% | Added |
| Sumitomo Mitsui Trust Holdings, Inc. | 0 | $0 | 0.00% | −2,490,600−100.0% | Sold out |
| Nikko Asset Management Americas, Inc. | 0 | $0 | 0.00% | −2,490,600−100.0% | Sold out |
| Aristotle Atlantic Partners, LLC | 0 | $0 | 0.00% | −1,218,025−100.0% | Sold out |
| PFM Health Sciences, LP | 0 | $0 | 0.00% | −946,305−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −802,700−100.0% | Sold out |
| ARK Investment Management LLCSuperinvestorARK Invest | 0 | $0 | 0.00% | −775,787−100.0% | Sold out |
| Jacobs Levy Equity Management, Inc | 0 | $0 | 0.00% | −515,035−100.0% | Sold out |
| State of New Jersey Common Pension Fund D | 0 | $0 | 0.00% | −274,122−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −252,622−100.0% | Sold out |
| Velan Capital Investment Management LP | 0 | $0 | 0.00% | −240,000−100.0% | Sold out |
| Harvest Investment Services, LLC | 0 | $0 | 0.00% | −124,943−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −115,277−100.0% | Sold out |
| Ghost Tree Capital, LLC | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −66,526−100.0% | Sold out |
| Quantamental Technologies LLC | 0 | $0 | 0.00% | −40,384−100.0% | Sold out |
| Rockefeller Capital Management L.P. | 0 | $0 | 0.00% | −37,758−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −36,751−100.0% | Sold out |
| NinePointTwo Capital | 0 | $0 | 0.00% | −32,933−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −32,047−100.0% | Sold out |
| Innovis Asset Management LLC | 0 | $0 | 0.00% | −26,512−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −21,851−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −15,989−100.0% | Sold out |
| Foundations Investment Advisors, LLC | 0 | $0 | 0.00% | −15,041−100.0% | Sold out |
| Retirement Group, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Worth Asset Management, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Operose Advisors LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −231−100.0% | Sold out |
| EverSource Wealth Advisors, LLC | 0 | $0 | 0.00% | −228−100.0% | Sold out |
| Allworth Financial LP | 0 | $0 | 0.00% | −63−100.0% | Sold out |
| Pictet Asset Management SA | – | – | – | – | Not filed |
| Kistler-Tiffany Companies, LLC | – | – | – | – | Not filed |